- Home
- REAL vs SLNO Comparison
REAL vs SLNO Comparison
Compare REAL & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REAL | SLNO |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.3B |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | REAL | SLNO |
|---|---|---|
| Price | $14.58 | $38.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | $16.57 | ★ $112.70 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $662,789,000.00 | $98,675,000.00 |
| Revenue This Year | $17.10 | N/A |
| Revenue Next Year | $10.90 | $157.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.30 | N/A |
| 52 Week Low | $4.61 | $37.95 |
| 52 Week High | $17.39 | $90.32 |
Technical Indicators
Market Signals| Indicator | REAL | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 29.02 |
| Support Level | $15.14 | $41.34 |
| Resistance Level | $16.50 | $43.31 |
| Average True Range (ATR) | 0.88 | 2.07 |
| MACD | -0.25 | -0.13 |
| Stochastic Oscillator | 1.75 | 0.15 |
Price Performance
Historical ComparisonAbout REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.